Recent evidence suggests that LSD1 ablation induces anti-tumor immunity by upregulating ERVs and disrupting the RNA-induced silencing complex, which leads to dsRNA accumulation and IFN β-dependent immune responses. The gene discussed is KDM1A; the disease is neoplasm.